临床药师参与的114次感染患者药学会诊分析  

Analysis of 114 times of pharmaceutical consultation of infected patients participated by clinical pharmacists

作　　者：何青青 田娜妮 朱琳 梁乐 白婷 杨蕊 李霄 惠娇娇 HE Qingqing;TIAN Nani;ZHU Lin;LIANG Le;BAI Ting;YANG Rui;LI Xiao;HUI Jiaojiao(Pharmacy Department,the First People's Hospital of Xianyang,Xianyang 712000,China)

机构地区：[1]咸阳市第一人民医院药学部,陕西咸阳712000

出　　处：《临床医学研究与实践》2022年第33期145-148,153,共5页Clinical Research and Practice

摘　　要：目的分析临床药师参与感染性疾病药学会诊的病例,探讨临床药师参与临床药学工作的切入点。方法选取2018年7月1日至2021年6月30日外科病区临床药师会诊的96例患者的114次感染性疾病的药学会诊。采用WPS2021统计数据,SPSS25.0分析数据,探究药师参与感染患者药学会诊价值。结果114次药学会诊中,排名前三的科室为骨科40次(35.1%)、神经外科30次(26.3%)、泌尿外科23次(20.2%);主要感染类型为呼吸系统感染25次(21.9%)、皮肤软组织及切口感染25次(21.9%)、泌尿系感染20次(17.5%);排名前三的会诊目的为细菌培养阳性制定优选抗菌药物44次(38.6%)、不明原因发热18次(15.8%)、前期方案不佳,调整用药17次(14.9%);排名前三的会诊建议为继续原有抗感染治疗方案43次(37.7%)、调整抗菌药物类型42次(36.8%)、完善相关检查评估患者病情12次(10.5%)。临床药师调整用药的方案中,调整为特殊使用级的为17次、限制使用级的为23次、非限制使用级的19次。114次药学会诊中,共采纳97次(85.1%)。会诊意见采纳的治疗总有效率高于未采纳(P<0.05)。结论临床药师参与感染患者的药学会诊可以提高感染性疾病的治愈率。Objective To analyze the cases of clinical pharmacists participating in pharmaceutical consultation of infectious diseases,and explore the entry point of clinical pharmacists participating in clinical pharmaceutical work.Methods A total of 114 pharmaceutical consultations of 96 patients with infectious diseases from July 1,2018 to June 30,2021 were selected,WPS 2021 was used to statistical data,SPSS 25.0 was used to analyze data,the value of pharmacists participating in pharmaceutical consultation for infected patients was explored.Results In 114 pharmaceutical consultations,the top three departments were orthopaedics department 40 times(35.1%),neurosurgery department 30 times(26.3%)and urological department 23 times(20.2%);the major types of infection were respiratory infection 25 times(21.9%),skin and soft tissue and incision infection 25 times(21.9%)and urinary tract infection 20 times(17.5%);the top three consultation purposes were formulation of optimal antimicrobial agents with positive bacterial culture 44 times(38.6%),fever of unknown origin 18 times(15.8%)and poor early plan,adjust medication 17 times(14.9%);the top three consultation recommendations were continue the original anti infection treatment scheme 43 times(37.7%),adjust the type of antibacterial agents 42 times(36.8%)and improve relevant examinations to evaluate the patient's condition 12 times(10.5%).In the adjustment plan of clinical pharmacists,17 times were adjusted to special use level,23 times to restricted use level and 19 times to unrestricted use level.In 114 pharmaceutical consultations,adopted 97 times(85.1%).The total effective rate of treatment adopted by consultation opinions was higher than that of not adopted(P<0.05).Conclusion Clinical pharmacists participating in pharmaceutical consultation of infected patients can improve the cure rate of infectious diseases.

关 键 词：临床药师 药学会诊 感染疾病 

分 类 号：R51[医药卫生—内科学]